Diffuse alveolar hemorrhage and recombinant factor VIIa treatment in pediatric patients
Diffuse alveolar hemorrhage (DAH) is a life-threatening pulmonary complication in patients with hematologic malignancies or autoimmune disorders. The current treatment options, which include corticosteroids, transfusions, extracorporeal membrane oxygenation (ECMO), and immunosuppressants, have been...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Pediatric Society
2016-03-01
|
| Series: | Korean Journal of Pediatrics |
| Subjects: | |
| Online Access: | http://kjp.or.kr/upload/pdf/kjped-59-105.pdf |